An Item Response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies.
about
An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriersThe Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive DisorderAn evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.Measuring depression: comparison and integration of three scales in the GENDEP study.Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scalesMeasuring depression using item response theory: an examination of three measures of depressive symptomatology.Scale matters: the need for a Bipolar Depression Rating Scale (BDRS).Specific Pharmacological Effects of Paroxetine Comprise Psychological but Not Somatic Symptoms of Depression.Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sampleSymptom features of postpartum depression: are they distinct?Assessment of outcome in depression.Prevalence and Clinical Correlates of Insomnia in Depressive Disorders: The CRESCEND Study.Exploring the Validity of the Short Version of the Problem Behaviours Assessment (PBA-s) for Huntington's disease: A Rasch Analysis.Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromalThe Inventory Of Depressive Symptomatology (IDS-C(28)) is more sensitive to changes in depressive symptomatology than the Hamilton Depression Rating Scale (HAMD(17)) in patients with mild major, minor or subsyndromal depression.Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol.
P2860
Q24615427-792B4B73-D3DF-42CF-A234-5D076DC69C55Q28079932-5ED9DF7D-BB7E-46C1-91FE-C5C906C70052Q34090610-BDADD7D0-BCEF-4A78-BFC2-0F0DEE6D739BQ34699544-1DFB02BB-A9A3-4198-A6B9-79B856B4A6DDQ35019889-739A4EE6-ED18-4323-AFA5-EF44F2A17723Q35828016-8FD027AA-0FEA-462C-A820-EE1E3DE26A68Q35872076-C3425BCA-566D-486E-8F2E-A9C1EB065816Q36082786-83B821AA-3D02-4102-8DAF-6DCF86BF1EDAQ36183614-BC634FD3-5417-4266-A515-6B332C90AA8CQ36498622-6BD7B258-C802-4B66-8624-77E07D891C2AQ36511681-F356A59E-E4DF-40D7-9293-72E066D449B4Q37516066-17AFB4BE-EDB4-416F-B678-5A56D539785DQ40118236-3F5FAC84-844C-4464-B60D-25C596CB2966Q45928384-D65AA298-8316-43BD-AC79-E39701A48D6BQ45964908-DF616F06-CE01-41D2-A35B-B5C0AB2F93DAQ48759820-A1E42EEE-E22B-485D-B247-8C99C0DBAECB
P2860
An Item Response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
An Item Response analysis of t ...... two pharmaceutical companies.
@ast
An Item Response analysis of t ...... two pharmaceutical companies.
@en
type
label
An Item Response analysis of t ...... two pharmaceutical companies.
@ast
An Item Response analysis of t ...... two pharmaceutical companies.
@en
prefLabel
An Item Response analysis of t ...... two pharmaceutical companies.
@ast
An Item Response analysis of t ...... two pharmaceutical companies.
@en
P2093
P1476
An Item Response analysis of t ...... two pharmaceutical companies.
@en
P2093
Darcy Santor
David J DeBrota
Nina Engelhardt
Steve Gelwicks
Terrence Sills
P304
P356
10.1016/J.JPSYCHIRES.2003.11.003
P577
2004-05-01T00:00:00Z